These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 3103957)
21. Myelopathy due to diffuse thickening of the cervical dura mater in Maroteaux-Lamy syndrome: report of a case. Tamaki N; Kojima N; Tanimoto M; Suyama T; Matsumoto S Neurosurgery; 1987 Sep; 21(3):416-9. PubMed ID: 3118237 [TBL] [Abstract][Full Text] [Related]
22. Bone marrow transplantation in Maroteaux-Lamy syndrome (MPS type 6): status 40 months after BMT. McGovern MM; Ludman MD; Short MP; Steinfeld L; Kattan M; Raab EL; Krivit W; Desnick RJ Birth Defects Orig Artic Ser; 1986; 22(1):41-53. PubMed ID: 3083886 [No Abstract] [Full Text] [Related]
23. Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). An intermediate clinical phenotype caused by substitution of valine for glycine at position 137 of arylsulfatase B. Wicker G; Prill V; Brooks D; Gibson G; Hopwood J; von Figura K; Peters C J Biol Chem; 1991 Nov; 266(32):21386-91. PubMed ID: 1718978 [TBL] [Abstract][Full Text] [Related]
24. Proceedings: The defect in Maroteaux-Lamy disease (mucopolysaccharidosis VI, subtype A): deficiency of N-acetylgalactosamine-4-sulfatase. O'Brien JF; Spranger J; Cantz M Hoppe Seylers Z Physiol Chem; 1974 Oct; 355(10):1235. PubMed ID: 4218834 [No Abstract] [Full Text] [Related]
25. Clearing of cornea after perforating keratoplasty in mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome). Naumann G N Engl J Med; 1985 Apr; 312(15):995. PubMed ID: 3919302 [No Abstract] [Full Text] [Related]
26. Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes. Isbrandt D; Arlt G; Brooks DA; Hopwood JJ; von Figura K; Peters C Am J Hum Genet; 1994 Mar; 54(3):454-63. PubMed ID: 8116615 [TBL] [Abstract][Full Text] [Related]
27. Aortic stenosis and mucopolysaccharidosis. Wilson CS; Mankin HT; Pluth JR Ann Intern Med; 1980 Apr; 92(4):496-8. PubMed ID: 6767429 [TBL] [Abstract][Full Text] [Related]
28. [Mucopolysaccharidosis 6-A (Maroteaux-Lamy disease): comparison of clinical and pathologico-anatomic findings in a 27-year-old patient]. Keller C; Briner J; Schneider J; Spycher M; Rampini S; Gitzelmann R Helv Paediatr Acta; 1987; 42(4):317-33. PubMed ID: 3127360 [TBL] [Abstract][Full Text] [Related]
29. Compressive myelopathy associated with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). Wald SL; Schmidek HH Neurosurgery; 1984 Jan; 14(1):83-8. PubMed ID: 6420724 [TBL] [Abstract][Full Text] [Related]
30. [Lamellar keratoplasty in congenital mucopolysaccharidosis of the Maroteaux-Lamy type]. Markicheva NA Vestn Oftalmol; 1985; 101(6):63-5. PubMed ID: 3938099 [No Abstract] [Full Text] [Related]
31. The pathology of the feline model of mucopolysaccharidosis VI. Haskins ME; Aguirre GD; Jezyk PF; Patterson DF Am J Pathol; 1980 Dec; 101(3):657-74. PubMed ID: 6778219 [TBL] [Abstract][Full Text] [Related]
32. Empty sella syndrome in a boy with mucopolysaccharidosis type VI (Maroteaux-Lamy). Von Mühlendahl KE; Bradac GB Helv Paediatr Acta; 1975 Jul; 30(2):185-90. PubMed ID: 807539 [TBL] [Abstract][Full Text] [Related]
33. Syringomyelia in mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): imaging findings following bone marrow transplantation. Hite SH; Krivit W; Haines SJ; Whitley CB Pediatr Radiol; 1997 Sep; 27(9):736-8. PubMed ID: 9285734 [TBL] [Abstract][Full Text] [Related]
34. [Analysis of clinical features and arylsulfatase B gene mutation in thirteen Chinese children with mucopolysaccharidosis type VI]. Zheng J; Huang Y; Zhao X; Sheng H; Cheng J; Zhou Z; Li X; Mao X; Liu L Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):403-8. PubMed ID: 25190157 [TBL] [Abstract][Full Text] [Related]
35. The oral manifestations of Maroteaux-Lamy syndrome (mucopolysaccharidosis VI): a case report. Alpöz AR; Coker M; Celen E; Ersin NK; Gökçen D; van Diggelenc OP; Huijmansc JG Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 May; 101(5):632-7. PubMed ID: 16632276 [TBL] [Abstract][Full Text] [Related]
36. An N-acetylgalactosamine-4-sulfatase mutation (delta G238) results in a severe Maroteaux-Lamy phenotype. Litjens T; Morris CP; Robertson EF; Peters C; von Figura K; Hopwood JJ Hum Mutat; 1992; 1(5):397-402. PubMed ID: 1301949 [TBL] [Abstract][Full Text] [Related]
37. The enzymic defects in Morquio and Maroteaux-Lamy syndrome. Dorfman A; Arbogast B; Matalon R Adv Exp Med Biol; 1976; 68():261-76. PubMed ID: 820169 [No Abstract] [Full Text] [Related]
38. The constellation of skeletal deformities in a family with mixed types of mucopolysaccharidoses: Case report. Kaissi AA; Hofstaetter J; Weigel G; Grill F; Ganger R; Kircher SG Medicine (Baltimore); 2016 Aug; 95(32):e4561. PubMed ID: 27512882 [TBL] [Abstract][Full Text] [Related]
39. Compressive myelopathy in Maroteaux-Lamy syndrome: clinical and pathological findings. Young R; Kleinman G; Ojemann RG; Kolodny E; Davis K; Halperin J; Zalneraitis E; DeLong GR Ann Neurol; 1980 Sep; 8(3):336-40. PubMed ID: 6776877 [TBL] [Abstract][Full Text] [Related]
40. Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) with hearing impairment and pupillary membrane remnants. Shigematsu Y; Hori C; Nakai A; Kuriyama M; Kikawa Y; Konishi Y; Sudo M; Konishi K Acta Paediatr Jpn; 1991 Aug; 33(4):476-81. PubMed ID: 1792906 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]